Research Topics
| Elly A StolkSummaryAffiliation: Erasmus MC Country: The Netherlands Publications
|
Detail Information
Publications
The "health benefit basket" in the NetherlandsElly A Stolk
Institute for Medical Technology Assessment, University Medical Center, Rotterdam, The Netherlands
Eur J Health Econ . 2005..It is conceivable, however, that the recent introduction of the DBC financing system will change the reimbursement and therefore benefit-setting policy...
Acceptability of less than perfect health statesWerner B F Brouwer
Institute for Medical Technology Assessment, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
Soc Sci Med 60:237-46. 2005..The acceptability of health states is related to the quality of life score of these states, i.e., worse states are considered less acceptable. This may have implications for the allocation of scarce health care resources...- Are patients and the general public like-minded about the effect of erectile dysfunction on quality of life?Elly A Stolk
Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands
Urology 61:810-5. 2003..Unfortunately, little is known about the social values for treatments of erectile dysfunction (ED). To solve this problem, we compared the values of patients and the general population for ED... - Reconciliation of economic concerns and health policy: illustration of an equity adjustment procedure using proportional shortfallElly A Stolk
Institute for Medical Technology Assessment, Rotterdam, Erasmus MC Rotterdam, The Netherlands
Pharmacoeconomics 22:1097-107. 2004..It is recommended that cost-effectiveness driven health policy systems consider equity adjustments... 
Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5DMatthijs M Versteegh
Erasmus University of Rotterdam, Rotterdam, The Netherlands
Med Decis Making 32:554-68. 2012..We mapped QLQ-C30, HAQ, and MSIS-29 on the EQ-5D and compared the quality of the mapping functions with statistical and clinical indicators...- Role of health technology assessment in shaping the benefits package in The NetherlandsElly A Stolk
Institute for Medical Technology Assessment, and Institute of Health Policy and Management, Erasmus MC, Rotterdam, The Netherlands
Expert Rev Pharmacoecon Outcomes Res 9:85-94. 2009.... - Validity and feasibility of the use of condition-specific outcome measures in economic evaluationElly A Stolk
Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands
Qual Life Res 12:363-71. 2003..An alternative strategy is to attribute utility scores to health states of a condition-specific outcomes measure (CSOM). We explored the validity and feasibility of this strategy... - Dear policy maker: have you made up your mind? A discrete choice experiment among policy makers and other health professionalsMarc A Koopmanschap
Erasmus University Medical Center, Rotterdam, The Netherlands
Int J Technol Assess Health Care 26:198-204. 2010..The aim of this study was to get insight in what criteria as presented in Health technology assessment (HTA) studies are important for decision makers in healthcare priority setting... - Willingness to pay for lives saved by Helicopter Emergency Medical ServicesAkkie N Ringburg
Department of Surgery Traumatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Prehosp Emerg Care 13:37-43. 2009..For this, the preferences of the general public towards both the positive effects and negative consequences of HEMS should be taken into account. Therefore, the willingness to pay (WTP) for lives saved by HEMS was calculated... - The valuation of the International Prostate Symptom Score (IPSS) for use in economic evaluationsEsther T Kok
Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
Eur Urol 42:491-7. 2002..The valuation of the IPSS facilitates economic evaluations of treatments for LUTS suggestive of BPO, because QALYs (the preferred outcome measure in health economics) can be determined empirically... - Discrete choice modeling for the quantification of health states: the case of the EQ-5DElly A Stolk
Institute for Medical Technology Assessment and Department of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands
Value Health 13:1005-13. 2010..The aim of our study was to determine whether the values derived from a DC experiment are comparable to those obtained using other valuation techniques, in particular the time trade-off (TTO)... - Condition-specific preference-based measures: benefit or burden?Matthijs M Versteegh
iMTA iBMG, Institute of Health Policy and Management Institute for Medical Technology Assessment, Erasmus University of Rotterdam, Rotterdam, The Netherlands
Value Health 15:504-13. 2012..To overcome this problem, new condition-specific PBMs (CS-PBMs) are being developed, but it is not yet clear how such measures compare with existing generic PBMs... - The cost-effectiveness of treatment for congenital diaphragmatic herniaMarten J Poley
institute for Medical Technology Assessment (iMTA) and the Department of Pediatric Surgery, Sophia Children's Hospital, University Hospital Rotterdam, Erasmus University Rotterdam, Rotterdam, The Netherlands
J Pediatr Surg 37:1245-52. 2002..The results of this study provide convincing evidence that treatment for CDH is indeed cost effective... - Rationalising rationing: economic and other considerations in the debate about funding of ViagraElly A Stolk
Institute for Medical Technology Assessment, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
Health Policy 59:53-63. 2002..In this paper, we try to demonstrate how these criteria were presented in the Viagra discussion and we will indicate how these criteria can be operationalised in relation to the outcomes of a cost-effectiveness analysis... - Equity in health care prioritisation: an empirical inquiry into social valueElly A Stolk
Institute for Medical Technology Assessment iMTA, Erasmus MC, P O Box 1738, 3000 DR Rotterdam, The Netherlands
Health Policy 74:343-55. 2005..This raises the question if health care decision makers evaluate the claims of different patients for health care by appropriate criteria... - Inequalities in oncology care: Economic consequences of high cost drugsMaartje G H Niezen
Institute for Health Policy and Management, Erasmus MC Rotterdam, P O Box 1738, 3000 DR Rotterdam, The Netherlands
Eur J Cancer 42:2887-92. 2006..If no other policies are applied, health care goals will no longer be met. This paper tries to map the contours of the current problem and its possible solutions. It is time governments take up their responsibility and take back control... - Assessing the introduction of universal varicella vaccination in the NetherlandsHein J Boot
Laboratory of Vaccine Preventable Diseases, National Institute for Public Health and the Environment RIVM, P O Box 1, 3720 BA Bilthoven, The Netherlands
Vaccine 24:6288-99. 2006..Despite these uncertainties it is clear that universal childhood vaccination will prevent most of the varicella related GP-visits, hospitalizations, and deaths...